Name: UMIN ID:
Unique ID issued by UMIN | UMIN000046603 |
---|---|
Receipt number | R000053163 |
Scientific Title | Humoral and T-cell responses to a third dose of BNT162b2 and mRNA-1273 COVID-19 Vaccine in Patients with hematological diseases treated with rituximab or obinutuzumab: An observational study. |
Date of disclosure of the study information | 2022/01/11 |
Last modified on | 2023/01/12 15:06:04 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2022/01/11 22:27:16 | ||
2 | Update | 2022/03/05 19:36:44 | Recruitment status Date of IRB |
|
3 | Update | 2022/07/13 11:20:52 | Number of participants that the trial has enrolled |
|
4 | Update | 2023/01/12 15:06:04 | Recruitment status |